Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-026952
Date:2021-04-14
Issuer: REGULUS THERAPEUTICS INC. (RGLS)
Original Submission Date:

Reporting Person:

HAGAN JOSEPH P
C/O REGULUS THERAPEUTICS INC.
10628 SCIENCE CENTER DR., #225 SAN DIEGO, CA 92121

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-04-14 C 75,850 a $0.00 320,478 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
CLASS A-2 CONVERTIBLE PREFERRED STOCK 0.0 2021-04-14 deemed execution date C 7,585 (a) common stock 7,585 $0.00 0 indirect pacific premier trust obo joseph p. hagan ira
Footnotes
IDfootnote
f1 the shares of class a-2 convertible preferred stock have no expiration date and are convertible at any time at the election of the holder into shares of common stock without payment of further consideration. each share of class a-2 convertible preferred stock converts into 10 shares of common stock.

Elevate your investments